Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma.
Bourdin A, Shaw D, Menzies-Gow A, FitzGerald JM, Bleecker ER, Busse WW, Ferguson GT, Brooks L, Barker P, Gil EG, Martin UJ.
Bourdin A, et al. Among authors: busse ww.
J Asthma. 2021 Apr;58(4):514-522. doi: 10.1080/02770903.2019.1705333. Epub 2019 Dec 26.
J Asthma. 2021.
PMID: 31859541
Free article.
Clinical Trial.